Ozturker Can, Purevdorj Bayasgalan, Karabulut Gamze Ozturk, Seif Gamal, Fazil Korhan, Khan Yasser Anwar, Kaynak Pelin
Department of Ophthalmic Plastic and Reconstructive Surgery, Istanbul Beyoglu Eye Research and Training Hospital, Bereketzade Cami Sk. No. 2, Beyoglu, Istanbul 34421, Turkey.
Division of Ophthalmology, Department of Surgery, Faculty of Health Sciences, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.
J Ophthalmol. 2022 Mar 23;2022:3996854. doi: 10.1155/2022/3996854. eCollection 2022.
To compare the outcomes of transcanalicular diode laser-assisted dacryocystorhinostomy (TCL-DCR), nonendoscopic endonasal dacryocystorhinostomy (NEN-DCR), and external dacryocystorhinostomy (EXT-DCR) as first-line treatments for functional epiphora.
This multicenter, retrospective, case-control study included 135 eyes of 135 patients with functional epiphora (86 females and 49 males). Functional epiphora was diagnosed based on a patent lacrimal system with a delay in the fluorescein dye disappearance test (FDDT) or dacryoscintigraphy (DSG) and no ocular surface or eyelid abnormalities. The patients were treated with TCL-DCR (2008-2011) or Ext-DCR (2005-2008, 2011-2017) at Beyoglu Eye Research Hospital (Istanbul, Turkey) and NEN-DCR at Carrot Eye Surgery Clinic affiliated with the McMaster University (Hamilton, ON, Canada) (2010-2016). Success was defined as the absence of epiphora and the normalization of an earlier delayed FDDT after surgery.
The TCL-DCR, NEN-DCR, and EXT-DCR groups consisted of 38, 47, and 50 eyes with 25.9, 44.2, and 45.9 months of follow-up. The success rate for TCL-DCR was 65.8%, 70.2% for NEN-DCR, and 84.0% for EXT-DCR. During the follow-up period, 13.2% of TCL-DCR cases and 6.4% of NEN-DCR cases developed an anatomic obstruction of the lacrimal system.
The EXT-DCR group had a higher success rate in the management of functional epiphora than the NEN-DCR and TCL-DCR groups and was significantly safer in terms of an iatrogenic anatomic block of the lacrimal system.
比较经泪小管二极管激光辅助泪囊鼻腔吻合术(TCL-DCR)、非内镜鼻内泪囊鼻腔吻合术(NEN-DCR)和外路泪囊鼻腔吻合术(EXT-DCR)作为功能性溢泪一线治疗方法的疗效。
这项多中心、回顾性病例对照研究纳入了135例功能性溢泪患者的135只眼(86例女性和49例男性)。功能性溢泪是基于泪道系统通畅,但荧光素染料消失试验(FDDT)或泪道闪烁造影(DSG)延迟,且无眼表或眼睑异常而诊断的。患者在贝伊奥卢眼科研究医院(土耳其伊斯坦布尔)接受TCL-DCR治疗(2008 - 2011年)或Ext-DCR治疗(2005 - 2008年、2011 - 2017年),在麦克马斯特大学附属胡萝卜眼科诊所(加拿大安大略省汉密尔顿)接受NEN-DCR治疗(2010 - 2016年)。成功定义为术后无溢泪且早期延迟的FDDT恢复正常。
TCL-DCR组、NEN-DCR组和EXT-DCR组分别有38只、47只和50只眼,随访时间分别为25.9个月、44.2个月和45.9个月。TCL-DCR的成功率为65.8%,NEN-DCR为70.2%,EXT-DCR为84.0%。在随访期间,13.2%的TCL-DCR病例和6.4%的NEN-DCR病例出现了泪道系统的解剖性阻塞。
在功能性溢泪的治疗中,EXT-DCR组的成功率高于NEN-DCR组和TCL-DCR组,且在泪道系统医源性解剖阻塞方面明显更安全。